Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Ataga · SciRah

Researcher profile · Semantic Scholar

K. Ataga

Share profile

K. Ataga — researcher profile on SciRah

h-index: 48
Works: 278
Citations: 9,834

Most-cited papers

The nephropathy of sickle cell trait and sickle cell disease
K. Ataga, Santosh L. Saraf, V. Derebail
2022Nature Reviews Nephrology106 citations Open access
Semantic Scholar
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
J. Howard, K. Ataga, R. Brown, M. Achebe +8 more
2021The Lancet Haematology86 citations
Semantic Scholar
Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis
K. Ataga, V. Gordeuk, I. Agodoa, J. Colby +2 more
2020PLoS ONE43 citations Open access
Semantic Scholar
Drug Therapies for the Management of Sickle Cell Disease
Parul Rai, K. Ataga
2020F1000Research42 citations Open access
Semantic Scholar
Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel
Deva Sharma, I. Kozanoglu, K. Ataga, A. Benachi +8 more
2024Blood Advances27 citations Open access
Semantic Scholar
Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline.
Hyeun Ah Kang, Bo-Fei Wang, J. Barner, K. Ataga +3 more
2024JAMA Internal Medicine27 citations Open access
Semantic Scholar
Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.
Miguel R. Abboud, Rodolfo D. Cançado, M. de Montalembert, Wally R. Smith +10 more
2025The Lancet Haematology24 citations
Semantic Scholar
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis
K. Ataga, Qing-Ning Zhou, V. Derebail, Santosh L. Saraf +6 more
2020Haematologica23 citations Open access
Semantic Scholar
Using Machine Learning to Predict Early Onset Acute Organ Failure in Critically Ill Intensive Care Unit Patients With Sickle Cell Disease: Retrospective Study
Akram Mohammed, P. Podila, R. Davis, K. Ataga +2 more
2020Journal of Medical Internet Research20 citations Open access
Semantic Scholar
Haemoglobin response to senicapoc in patients with sickle cell disease: a re‐analysis of the Phase III trial
K. Ataga, Steven J. Staffa, C. Brugnara, J. Stocker
2021British Journal of Haematology19 citations
Semantic Scholar
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.
M. Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse L. C. Lobo +24 more
2024The Lancet Haematology17 citations
Semantic Scholar
Patients with Sickle Cell Disease who develop End Stage Kidney Disease continue to experience poor survival, a 19- year USRDS Study
Jeffrey C. Winer, M. Yee, K. Ataga, Jeffrey D. Lebensburger +1 more
2022British Journal of Haematology17 citations Open access
Semantic Scholar
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
K. Ataga, Qing-Ning Zhou, Santosh L. Saraf, J. Hankins +7 more
2022Blood Advances16 citations Open access
Semantic Scholar
High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia
Jeffrey D. Lebensburger, J. Gossett, R. Zahr, Winfred C. Wang +4 more
2020Haematologica16 citations Open access
Semantic Scholar
The Challenge of Clinical Endpoints in Sickle Cell Disease.
K. Ataga
2023Blood15 citations
Semantic Scholar
TRANSITION CARE CONTINUITY PROMOTES LONG-TERM RETENTION IN ADULT CARE AMONG YOUNG ADULTS WITH SICKLE CELL DISEASE
Kristen E Howell, Anjelica C Saulsberry-Abate, Joacy G Mathias, Jerlym S. Porter +5 more
2021Pediatric Blood & Cancer14 citations Open access
Semantic Scholar
Higher Hemoglobin Levels Achieved with Voxelotor Are Associated with Lower Vaso-occlusive Crisis Incidence: 72-Week Analysis from the HOPE Study
E. Vichinsky, V. Gordeuk, P. Telfer, A. Inati +4 more
202014 citations Open access
Semantic Scholar
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi
G. Tegha, H. Topazian, P. Kamthunzi, T. Howard +9 more
2021International Journal of Public Health13 citations Open access
Semantic Scholar
Longitudinal Study of Glomerular Hyperfiltration and Normalization of Estimated Glomerular Filtration in Adults with Sickle Cell Disease
V. Derebail, Qing-Ning Zhou, E. Ciccone, Jian-Wen Cai +1 more
2021British Journal of Haematology13 citations Open access
Semantic Scholar
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial
M. Gladwin, V. Gordeuk, P. Desai, C. Minniti +25 more
2024The Lancet Haematology12 citations
Semantic Scholar
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
Parul Rai, V. Joshi, J. Goldberg, Amber M. Yates +5 more
2021Blood Advances10 citations Open access
Semantic Scholar
Kidney Failure Outcomes in Children and Young Adults with Sickle Cell Disease in the United States Renal Data System
R. Zahr, K. Ataga, Jeffrey D. Lebensburger, Jeffrey C. Winer
2023Pediatric nephrology (Berlin, West)9 citations Open access
Semantic Scholar
A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
Santosh L. Saraf, K. Ataga, V. Derebail, C. Sharpe +5 more
2021Blood8 citations Open access
Semantic Scholar
Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia
G. Champlin, Scott N. Hwang, Andrew M. Heitzer, Juan Ding +10 more
2021Experimental biology and medicine8 citations Open access
Semantic Scholar
Using disease-modifying therapies in sickle cell disease.
Parul Rai, K. Ataga
2023Hematology. American Society of Hematology. Education Program7 citations
Semantic Scholar
Comparative pharmacovigilance assessment of adverse events associated with the use of hydroxyurea, L‐glutamine, voxelotor, and crizanlizumab in sickle cell disease
Ming Chen, J. Hankins, Min Zhang, K. Ataga
2023American journal of hematology/oncology7 citations Open access
Semantic Scholar
The Evolving Landscape of Drug Therapies for Sickle Cell Disease.
Parul Rai, P. Desai, K. Ataga
2022Hematology/Oncology Clinics of North America7 citations Open access
Semantic Scholar
Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study
Laila Elsherif, L. Scott, D. Wichlan, S. Jones +4 more
2021British Journal of Haematology7 citations Open access
Semantic Scholar
Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
Kwaku Marfo, Yvonne Dei-Adomakoh, C. Segbefia, Duah Dwomoh +7 more
2023BMC Health Services Research6 citations Open access
Semantic Scholar
Sex differences in progression of kidney disease in sickle cell disease
K. Ataga, Qing-Ning Zhou, Santosh L. Saraf, J. Hankins +7 more
2022Haematologica6 citations Open access
Semantic Scholar
Trial in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase Ib CROSSWALK-a Trial Evaluating the Safety of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOEs) in Patients with Sickle Cell Disease (SCD)
P. Bartolucci, K. Ataga, M. Callaghan, L. De Franceschi +7 more
2021Blood6 citations Open access
Semantic Scholar
The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial
W. Smith, K. Ataga, Santosh L. Saraf, O. Adisa +5 more
20206 citations Open access
Semantic Scholar
Enhanced PIEZO1 Function Contributes to the Pathogenesis of Sickle Cell Disease
Luis O. Romero, Manisha Bade, Laila Elsherif, Jada D. Williams +6 more
2025bioRxiv5 citations Open access
Semantic Scholar
Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study
Laura Y. Zhou, V. Derebail, P. Desai, Laila Elsherif +11 more
2024British Journal of Haematology5 citations Open access
Semantic Scholar
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel
Julie Kanter, K. Ataga, Neha Bhasin, S. Guarino +9 more
2024Annals of Hematology5 citations
Semantic Scholar
Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease
Ming Chen, K. Ataga, J. Hankins, Min Zhang +3 more
2023Annals of Hematology5 citations
Semantic Scholar
Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anemia: SCCRIP cohort study results
Sara R. Rashkin, E. Rampersaud, G. Kang, K. Ataga +6 more
2021British Journal of Haematology5 citations Open access
Semantic Scholar
A pilot study of the effect of rivaroxaban in sickle cell anemia
K. Ataga, Laila Elsherif, D. Wichlan, A. Wogu +4 more
2021Transfusion5 citations
Semantic Scholar
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia
Laila Elsherif, Yi-Han Tang, Kammie L. Patillo, David Wichlan +16 more
2024British Journal of Haematology4 citations
Semantic Scholar
Hydroxyurea at Escalated Dose versus Fixed Low-Dose Hydroxyurea in Adults with Sickle Cell Disease
U. Ogu, Ayesha Mukhopadhyay, Kruti Patel, Marquita N Nelson +4 more
2023European Journal of Haematology4 citations
Semantic Scholar
Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia
Laila Elsherif, Praghalathan Kanthakumar, Jeremiah Afolabi, Ashley Stratton +6 more
2023British Journal of Haematology4 citations
Semantic Scholar
Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease
R. Zahr, Akram Mohammed, Surabhi Naik, Daniel Faradji +3 more
2022Blood4 citations Open access
Semantic Scholar
Using machine learning to predict rapid decline of kidney function in sickle cell anemia
Fatma Gunturkun, Daiqing Chen, O. Akbilgic, Robert L. Davis +5 more
2021eJHaem4 citations Open access
Semantic Scholar
An Adaptive, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE)
K. Wood, J. Geib, E. Wu, Jason Berlin +6 more
20204 citations Open access
Semantic Scholar
Enhanced PIEZO1 function contributes to the pathogenesis of sickle cell disease
Luis O. Romero, Manisha Bade, Laila Elsherif, Jada D. Williams +6 more
2025Proceedings of the National Academy of Sciences of the United States of America3 citations Open access
Semantic Scholar
Enuresis and Hyperfiltration in Children with Sickle Cell Disease
R. Zahr, Juan Ding, G. Kang, Winfred C. Wang +4 more
2022Journal of pediatric hematology/oncology3 citations Open access
Semantic Scholar
P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
M. Callaghan, K. Ataga, L. De Franceschi, C. Minniti +6 more
2022HemaSphere3 citations Open access
Semantic Scholar
Efficacy and Safety of Voxelotor in Adolescents and Adults with Sickle Cell Disease: HOPE Trial 72-Week Analysis
J. Howard, K. Ataga, R. Brown, M. Achebe +8 more
20203 citations Open access
Semantic Scholar
Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study
Julie Kanter, P. Patwari, P. Desai, K. Ataga +8 more
2023Blood2 citations Open access
Semantic Scholar
End Stage Kidney Disease Outcomes in Children and Young Adults with Sickle Cell Disease in the United States Renal Data System
R. Zahr, K. Ataga, Jeffrey D. Lebensburger, Jeffrey C. Winer
2023Research Square2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Hankins×12
Invite
J. Hankins — researcher profile on SciRah
V. Derebail×8
Invite
V. Derebail — researcher profile on SciRah
Jeffrey D. Lebensburger×8
Invite
Jeffrey D. Lebensburger — researcher profile on SciRah
Santosh L. Saraf×7
Invite
Santosh L. Saraf — researcher profile on SciRah

×7

Invite

R. Zahr — researcher profile on SciRah

Laila Elsherif×7

Invite

Laila Elsherif — researcher profile on SciRah

Invite

G. Kang — researcher profile on SciRah

Invite

I. Agodoa — researcher profile on SciRah

Invite

V. Gordeuk — researcher profile on SciRah

Invite

Parul Rai — researcher profile on SciRah

Qing-Ning Zhou×4

Invite

Qing-Ning Zhou — researcher profile on SciRah

Jian-Wen Cai×4

Invite

Jian-Wen Cai — researcher profile on SciRah